Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative

OBJECTIVE: Most clinical trials for systemic lupus erythematosus (SLE) study the efficacy and safety of investigational agents added to variable background immunosuppressants, which has resulted in high response rates in patients treated with placebo plus standard of care (SOC) plus rescue measures....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Rheumatol
Main Authors: Kalunian, Kenneth Carekin, Kim, Mimi, Xie, Xianhong, Baskaran, Amrutha, Daly, Rossi Paola, Merrill, Joan Tenenbaum
Formato: Artigo
Idioma:Inglês
Publicado em: Medical Research and Education Association 2016
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5042268/
https://ncbi.nlm.nih.gov/pubmed/27708963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2015.0048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados